Natera Return on Investment 2014-2024 | NTRA
Current and historical return on investment (ROI) values for Natera (NTRA) over the last 10 years.
| Natera ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-09-30 | $-0.24B | $1.17B | -21.95% |
| 2024-06-30 | $-0.31B | $1.12B | -29.13% |
| 2024-03-31 | $-0.38B | $1.08B | -37.54% |
| 2023-12-31 | $-0.45B | $1.05B | -45.44% |
| 2023-09-30 | $-0.50B | $1.07B | -52.06% |
| 2023-06-30 | $-0.51B | $0.88B | -59.40% |
| 2023-03-31 | $-0.54B | $0.93B | -65.92% |
| 2022-12-31 | $-0.54B | $0.99B | -68.07% |
| 2022-09-30 | $-0.54B | $0.64B | -68.97% |
| 2022-06-30 | $-0.57B | $0.73B | -64.74% |
| 2022-03-31 | $-0.54B | $0.82B | -64.24% |
| 2021-12-31 | $-0.47B | $0.93B | -58.43% |
| 2021-09-30 | $-0.40B | $1.04B | -54.34% |
| 2021-06-30 | $-0.31B | $0.58B | -46.39% |
| 2021-03-31 | $-0.25B | $0.65B | -38.00% |
| 2020-12-31 | $-0.22B | $0.69B | -38.42% |
| 2020-09-30 | $-0.18B | $0.74B | -37.04% |
| 2020-06-30 | $-0.14B | $0.50B | -42.56% |
| 2020-03-31 | $-0.12B | $0.33B | -47.57% |
| 2019-12-31 | $-0.12B | $0.35B | -61.99% |
| 2019-09-30 | $-0.11B | $0.16B | -88.02% |
| 2019-06-30 | $-0.12B | $0.17B | -98.13% |
| 2019-03-31 | $-0.12B | $0.08B | -127.12% |
| 2018-12-31 | $-0.12B | $0.11B | -129.21% |
| 2018-09-30 | $-0.13B | $0.13B | -151.72% |
| 2018-06-30 | $-0.13B | $0.05B | -163.24% |
| 2018-03-31 | $-0.13B | $0.07B | -195.56% |
| 2017-12-31 | $-0.14B | $0.10B | -270.65% |
| 2017-09-30 | $-0.13B | $0.10B | -508.74% |
| 2017-06-30 | $-0.13B | inf% | |
| 2017-03-31 | $-0.13B | inf% | |
| 2016-12-31 | $-0.10B | inf% | |
| 2016-09-30 | $-0.08B | inf% | |
| 2016-06-30 | $-0.07B | -125.11% | |
| 2016-03-31 | $-0.06B | -85.42% | |
| 2015-12-31 | $-0.06B | -80.00% | |
| 2015-06-30 | $-0.02B | $0.07B | -94.12% |
| 2015-03-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.122B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.685B | 28.04 |
| Elevance Health (ELV) | United States | $90.559B | 11.84 |
| Cencora (COR) | United States | $47.572B | 17.32 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| ICON (ICLR) | Ireland | $16.164B | 14.40 |
| Avantor (AVTR) | United States | $14.769B | 22.14 |
| Revvity (RVTY) | United States | $14.502B | 24.32 |
| BioMerieux (BMXMF) | France | $14.256B | 0.00 |
| Viatris (VTRS) | United States | $13.010B | 4.01 |
| Solventum (SOLV) | United States | $12.919B | 0.00 |
| CochLear (CHEOY) | Australia | $12.848B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
| Doximity (DOCS) | United States | $10.877B | 56.56 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
| HealthEquity (HQY) | United States | $9.712B | 48.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
| BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
| Sotera Health (SHC) | United States | $3.909B | 20.91 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
| Concentras Parent (CON) | United States | $2.958B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
| PACS (PACS) | United States | $2.161B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
| Progyny (PGNY) | United States | $1.859B | 37.64 |
| GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
| Premier (PINC) | United States | $1.821B | 11.08 |
| GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.351B | 0.00 |
| CareDx (CDNA) | United States | $1.217B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
| Embecta (EMBC) | United States | $1.031B | 7.06 |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
| SBC Medicals (SBC) | United States | $0.533B | 0.00 |
| DocGo (DCGO) | United States | $0.501B | 18.89 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 35.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| Nutex Health (NUTX) | United States | $0.323B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
| LifeMD (LFMD) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.201B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| ModivCare (MODV) | United States | $0.062B | 3.35 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |